Cargando…

Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis

BACKGROUND: The World Health Organization targeted Trypanosoma brucei gambiense human African trypanosomiasis (gHAT) for elimination as a public health problem and for elimination of transmission. To measure gHAT elimination success with prevalences close to zero, highly specific diagnostics are nec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geerts, Manon, Van Reet, Nick, Leyten, Sander, Berghmans, Raf, Rock, Kat S, Coetzer, Theresa H T, Eyssen, Lauren E-A, Büscher, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563279/ https://www.ncbi.nlm.nih.gov/pubmed/32856049 http://dx.doi.org/10.1093/cid/ciaa1264

Ejemplares similares

Luminescent multiplex viability assay for Trypanosoma brucei gambiense
por: Van Reet, Nick, et al.
Publicado: (2013)

Target product profile: Trypanosoma brucei gambiense test to verify elimination
por: Priotto, Gerardo, et al.
Publicado: (2023)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

Deep kinetoplast genome analyses result in a novel molecular assay for detecting Trypanosoma brucei gambiense-specific minicircles
por: Geerts, Manon, et al.
Publicado: (2022)

The Genome Sequence of Trypanosoma brucei gambiense, Causative Agent of Chronic Human African Trypanosomiasis
por: Jackson, Andrew P., et al.
Publicado: (2010)

Target product profile: diagnostic test for Trypanosoma brucei gambiense
por: Priotto, Gerardo, et al.
Publicado: (2023)

Unusual MRI Findings in African Trypanosoma brucei gambiense Trypanosomiasis: Dentate Nuclei and Hypothalamic Lesions
por: Boukobza, Monique, et al.
Publicado: (2020)

Target product profile: Trypanosoma brucei gambiense test for low-prevalence settings
por: Priotto, Gerardo, et al.
Publicado: (2023)

Molecular evidence of a Trypanosoma brucei gambiense sylvatic cycle in the human african trypanosomiasis foci of Equatorial Guinea
por: Cordon-Obras, Carlos, et al.
Publicado: (2015)

Isolation of Trypanosoma brucei gambiense from Cured and Relapsed Sleeping Sickness Patients and Adaptation to Laboratory Mice
por: Pyana, Patient Pati, et al.
Publicado: (2011)

Untreated Human Infections by Trypanosoma brucei gambiense Are Not 100% Fatal
por: Jamonneau, Vincent, et al.
Publicado: (2012)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

Identification of Peptide Mimotopes of Trypanosoma brucei gambiense Variant Surface Glycoproteins
por: Van Nieuwenhove, Liesbeth Carolien, et al.
Publicado: (2011)

Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa
por: Sutherland, C Simone, et al.
Publicado: (2019)

Two-Year Follow-Up of Trypanosoma brucei gambiense Serology after Successful Treatment of Human African Trypanosomiasis: Results of Four Different Sero-Diagnostic Tests
por: Inocencio da Luz, Raquel, et al.
Publicado: (2022)

Melarsoprol Sensitivity Profile of Trypanosoma brucei gambiense Isolates from Cured and Relapsed Sleeping Sickness Patients from the Democratic Republic of the Congo
por: Pyana Pati, Patient, et al.
Publicado: (2014)

Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control
por: Stone, Chris M., et al.
Publicado: (2015)

Modelling gambiense human African trypanosomiasis infection in villages of the Democratic Republic of Congo using Kolmogorov forward equations
por: Davis, Christopher N., et al.
Publicado: (2021)

Identification of Trypanosoma brucei gambiense in naturally infected dogs in Nigeria
por: Umeakuana, Paschal Ugochukwu, et al.
Publicado: (2019)

Molecular Identification of Trypanosome Diversity in Domestic Animals Reveals the Presence of Trypanosoma brucei gambiense in Historical Foci of Human African Trypanosomiasis in Gabon
por: Boundenga, Larson, et al.
Publicado: (2022)

The elimination of Trypanosoma brucei gambiense? Challenges of reservoir hosts and transmission cycles: Expect the unexpected
por: Mehlitz, D., et al.
Publicado: (2019)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

Specificity of malaria rapid diagnostic tests is affected by Trypanosoma brucei gambiense sleeping sickness
por: Gillet, Philippe, et al.
Publicado: (2012)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

Evidence of the absence of human African trypanosomiasis in two northern districts of Uganda: Analyses of cattle, pigs and tsetse flies for the presence of Trypanosoma brucei gambiense
por: Cunningham, Lucas J., et al.
Publicado: (2020)

Recombinant Antigens Expressed in Pichia pastoris for the Diagnosis of Sleeping Sickness Caused by Trypanosoma brucei gambiense
por: Rogé, Stijn, et al.
Publicado: (2014)

Murine Models for Trypanosoma brucei gambiense Disease Progression—From Silent to Chronic Infections and Early Brain Tropism
por: Giroud, Christiane, et al.
Publicado: (2009)

Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections
por: Bucheton, B, et al.
Publicado: (2011)

A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense
por: Cooper, Anneli, et al.
Publicado: (2016)

Neural Damage in Experimental Trypanosoma brucei gambiense Infection: The Suprachiasmatic Nucleus
por: Tesoriero, Chiara, et al.
Publicado: (2018)

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo
por: Crump, Ronald E., et al.
Publicado: (2021)

Expression of Trypanosoma brucei gambiense Antigens in Leishmania tarentolae. Potential for Use in Rapid Serodiagnostic Tests (RDTs)
por: Rooney, Barrie, et al.
Publicado: (2015)

Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad
por: Antillon, Marina, et al.
Publicado: (2023)

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
por: Kande Betu Ku Mesu, Victor, et al.
Publicado: (2021)

Is vector control needed to eliminate gambiense human African trypanosomiasis?
por: Solano, Philippe, et al.
Publicado: (2013)

Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis
por: Simarro, Pere P., et al.
Publicado: (2015)

Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data
por: Davis, Christopher N, et al.
Publicado: (2021)

Correction: Murine Models for Trypanosoma brucei gambiense Disease Progression—From Silent to Chronic Infections and Early Brain Tropism
por: Giroud, Christiane, et al.
Publicado: (2016)

Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness
por: Tiberti, Natalia, et al.
Publicado: (2012)

Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad
por: Rock, Kat S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a108u0eqjadv2n64s45e2kb86l